Lexpert Ranked Lawyer Profile

Joel P. Rochon
Managing Partner

Rochon Genova LLP

Joel P. Rochon, Rochon Genova LLP

Joel Rochon is managing partner at Rochon Genova LLP and heads the firm’s class action practice with emphasis on product liability, securities, transportation law and consumer goods litigation. Joel’s achievements of note include the certification and settlement of the Wilson v. Servier Canada diet drugs litigation (the first defective drug case to be certified in Canada). Joel is or has been lead or co-lead counsel on a number of significant class actions including the $1.2 billion Nortel securities settlement, the landmark Toyota unintended acceleration litigation class action and resolution, VW Diesel defeat device litigation and settlement, numerous defective drug and medical device cases and the ongoing securities litigation involving CIBC, SNC Lavalin (resolved for $120 million), the SNC2 litigation, Barrick Gold, Aphria, market timing (CI and AIC) in mutual funds, and the Lac-Mégantic train disaster. Joel was admitted to the Ontario Bar in 1988.

Year Called to the Bar:1988 (ON)
121 Richmond St W, Suite 900
Toronto, ON
Phone: (416) 363-1867
Fax: (416) 363-0263
E-mail: jrochon@rochongenova.com

Read more about Joel P. Rochon in...

Big Deals, Suits or Real Estate Transactions

Mentioned in Lexpert Publications

  • Nov 08, 2017
    A look at the settlement of a class action lawsuit against Volkswagen Group Canada in a case involving vehicle emissions control systems software. The settlement, valued at up to $2.1 billion, is the ...
  • Feb 13, 2017
    After the disappointing jurisprudential results experienced by Canadian business in 2015, the landscape more than evened out this past year — which is not to say that Canadian appellate courts ...
  • Nov 18, 2016
    Each Canadian province has its own class-action statute, which means US clients may still face five or six overlapping class actions, each one bogged down by interlocutory motions and appeals.
  • Nov 27, 2015
    Damage caps and other restrictions for shareholder class actions appear to have worked. Whether that is a good thing depends who you ask